Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response

Vaccination is one of the most efficient public healthcare measures to fight infectious diseases. Nevertheless, the immune mechanisms induced in vivo by vaccination are still unclear. The route of administration, an important vaccination parameter, can substantially modify the quality of the respons...

Full description

Bibliographic Details
Main Authors: Pierre Rosenbaum, Nicolas Tchitchek, Candie Joly, André Rodriguez Pozo, Lev Stimmer, Sébastien Langlois, Hakim Hocini, Leslie Gosse, David Pejoski, Antonio Cosma, Anne-Sophie Beignon, Nathalie Dereuddre-Bosquet, Yves Levy, Roger Le Grand, Frédéric Martinon
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.645210/full
id doaj-3a103ecb80fc4060981474719f13c5bd
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Pierre Rosenbaum
Pierre Rosenbaum
Nicolas Tchitchek
Nicolas Tchitchek
Candie Joly
Candie Joly
André Rodriguez Pozo
André Rodriguez Pozo
Lev Stimmer
Lev Stimmer
Sébastien Langlois
Sébastien Langlois
Hakim Hocini
Hakim Hocini
Leslie Gosse
Leslie Gosse
David Pejoski
David Pejoski
Antonio Cosma
Antonio Cosma
Anne-Sophie Beignon
Anne-Sophie Beignon
Nathalie Dereuddre-Bosquet
Nathalie Dereuddre-Bosquet
Yves Levy
Yves Levy
Roger Le Grand
Roger Le Grand
Frédéric Martinon
Frédéric Martinon
spellingShingle Pierre Rosenbaum
Pierre Rosenbaum
Nicolas Tchitchek
Nicolas Tchitchek
Candie Joly
Candie Joly
André Rodriguez Pozo
André Rodriguez Pozo
Lev Stimmer
Lev Stimmer
Sébastien Langlois
Sébastien Langlois
Hakim Hocini
Hakim Hocini
Leslie Gosse
Leslie Gosse
David Pejoski
David Pejoski
Antonio Cosma
Antonio Cosma
Anne-Sophie Beignon
Anne-Sophie Beignon
Nathalie Dereuddre-Bosquet
Nathalie Dereuddre-Bosquet
Yves Levy
Yves Levy
Roger Le Grand
Roger Le Grand
Frédéric Martinon
Frédéric Martinon
Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response
Frontiers in Immunology
vaccine
innate & adaptive immune response
modified vaccinia Ankara (MVA)
non human primates
administration routes
mass cytometry (CyTOF)
author_facet Pierre Rosenbaum
Pierre Rosenbaum
Nicolas Tchitchek
Nicolas Tchitchek
Candie Joly
Candie Joly
André Rodriguez Pozo
André Rodriguez Pozo
Lev Stimmer
Lev Stimmer
Sébastien Langlois
Sébastien Langlois
Hakim Hocini
Hakim Hocini
Leslie Gosse
Leslie Gosse
David Pejoski
David Pejoski
Antonio Cosma
Antonio Cosma
Anne-Sophie Beignon
Anne-Sophie Beignon
Nathalie Dereuddre-Bosquet
Nathalie Dereuddre-Bosquet
Yves Levy
Yves Levy
Roger Le Grand
Roger Le Grand
Frédéric Martinon
Frédéric Martinon
author_sort Pierre Rosenbaum
title Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response
title_short Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response
title_full Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response
title_fullStr Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response
title_full_unstemmed Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response
title_sort vaccine inoculation route modulates early immunity and consequently antigen-specific immune response
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-04-01
description Vaccination is one of the most efficient public healthcare measures to fight infectious diseases. Nevertheless, the immune mechanisms induced in vivo by vaccination are still unclear. The route of administration, an important vaccination parameter, can substantially modify the quality of the response. How the route of administration affects the generation and profile of immune responses is of major interest. Here, we aimed to extensively characterize the profiles of the innate and adaptive response to vaccination induced after intradermal, subcutaneous, or intramuscular administration with a modified vaccinia virus Ankara model vaccine in non-human primates. The adaptive response following subcutaneous immunization was clearly different from that following intradermal or intramuscular immunization. The subcutaneous route induced a higher level of neutralizing antibodies than the intradermal and intramuscular vaccination routes. In contrast, polyfunctional CD8+ T-cell responses were preferentially induced after intradermal or intramuscular injection. We observed the same dichotomy when analyzing the early molecular and cellular immune events, highlighting the recruitment of cell populations, such as CD8+ T lymphocytes and myeloid-derived suppressive cells, and the activation of key immunomodulatory gene pathways. These results demonstrate that the quality of the vaccine response induced by an attenuated vaccine is shaped by early and subtle modifications of the innate immune response. In this immunization context, the route of administration must be tailored to the desired type of protective immune response. This will be achieved through systems vaccinology and mathematical modeling, which will be critical for predicting the efficacy of the vaccination route for personalized medicine.
topic vaccine
innate & adaptive immune response
modified vaccinia Ankara (MVA)
non human primates
administration routes
mass cytometry (CyTOF)
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.645210/full
work_keys_str_mv AT pierrerosenbaum vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT pierrerosenbaum vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT nicolastchitchek vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT nicolastchitchek vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT candiejoly vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT candiejoly vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT andrerodriguezpozo vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT andrerodriguezpozo vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT levstimmer vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT levstimmer vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT sebastienlanglois vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT sebastienlanglois vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT hakimhocini vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT hakimhocini vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT lesliegosse vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT lesliegosse vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT davidpejoski vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT davidpejoski vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT antoniocosma vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT antoniocosma vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT annesophiebeignon vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT annesophiebeignon vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT nathaliedereuddrebosquet vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT nathaliedereuddrebosquet vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT yveslevy vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT yveslevy vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT rogerlegrand vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT rogerlegrand vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT fredericmartinon vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
AT fredericmartinon vaccineinoculationroutemodulatesearlyimmunityandconsequentlyantigenspecificimmuneresponse
_version_ 1721518716090318848
spelling doaj-3a103ecb80fc4060981474719f13c5bd2021-04-20T04:54:52ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-04-011210.3389/fimmu.2021.645210645210Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune ResponsePierre Rosenbaum0Pierre Rosenbaum1Nicolas Tchitchek2Nicolas Tchitchek3Candie Joly4Candie Joly5André Rodriguez Pozo6André Rodriguez Pozo7Lev Stimmer8Lev Stimmer9Sébastien Langlois10Sébastien Langlois11Hakim Hocini12Hakim Hocini13Leslie Gosse14Leslie Gosse15David Pejoski16David Pejoski17Antonio Cosma18Antonio Cosma19Anne-Sophie Beignon20Anne-Sophie Beignon21Nathalie Dereuddre-Bosquet22Nathalie Dereuddre-Bosquet23Yves Levy24Yves Levy25Roger Le Grand26Roger Le Grand27Frédéric Martinon28Frédéric Martinon29UMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceUMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceUMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceUMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceINSERM, U1169, Kremlin-Bicêtre, FranceCEA – INSERM, MIRCen, UMS27, Fontenay-aux-Roses, FranceUMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceINSERM, U955, Team 16, Clinical and Infectious Diseases Department, Hospital Henri Mondor, University of Paris East, Créteil, FranceUMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceUMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceUMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceUMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceUMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceINSERM, U955, Team 16, Clinical and Infectious Diseases Department, Hospital Henri Mondor, University of Paris East, Créteil, FranceUMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceUMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay – INSERM U1184 – CEA, Fontenay-aux-Roses, FranceVaccine Research Institute, Henri Mondor Hospital, Créteil, FranceVaccination is one of the most efficient public healthcare measures to fight infectious diseases. Nevertheless, the immune mechanisms induced in vivo by vaccination are still unclear. The route of administration, an important vaccination parameter, can substantially modify the quality of the response. How the route of administration affects the generation and profile of immune responses is of major interest. Here, we aimed to extensively characterize the profiles of the innate and adaptive response to vaccination induced after intradermal, subcutaneous, or intramuscular administration with a modified vaccinia virus Ankara model vaccine in non-human primates. The adaptive response following subcutaneous immunization was clearly different from that following intradermal or intramuscular immunization. The subcutaneous route induced a higher level of neutralizing antibodies than the intradermal and intramuscular vaccination routes. In contrast, polyfunctional CD8+ T-cell responses were preferentially induced after intradermal or intramuscular injection. We observed the same dichotomy when analyzing the early molecular and cellular immune events, highlighting the recruitment of cell populations, such as CD8+ T lymphocytes and myeloid-derived suppressive cells, and the activation of key immunomodulatory gene pathways. These results demonstrate that the quality of the vaccine response induced by an attenuated vaccine is shaped by early and subtle modifications of the innate immune response. In this immunization context, the route of administration must be tailored to the desired type of protective immune response. This will be achieved through systems vaccinology and mathematical modeling, which will be critical for predicting the efficacy of the vaccination route for personalized medicine.https://www.frontiersin.org/articles/10.3389/fimmu.2021.645210/fullvaccineinnate & adaptive immune responsemodified vaccinia Ankara (MVA)non human primatesadministration routesmass cytometry (CyTOF)